A new drug approval for the vanguard of RNA-targeted small molecules

A few years ago, at Arrakis Therapeutics, we set out to conquer a strange new territory, drugging RNA structures with small molecules. We have overcome many obstacles on this mission, inventing new concepts and methods where necessary and re-engineering known concepts and methods where possible. But we have not been the only people on this […] The post A new drug approval for the vanguard of RNA-targeted small molecules appeared first on Arrakis Therapeutics .